By Vuk Ćatović · 8 min read · AI and Machine Learning
Walk into almost any large healthcare or life sciences organization and you will find at least one AI project that delivered. It routed the right case to the right specialist, drafted the first version of a report, flagged an anomaly a human might have missed, or handed a stretched team hours back in the week. The proof of concept did its job.
Then it stopped there. The result that landed in one ward, one trial, or one analytics team rarely becomes the way the whole organization runs. Plenty of teams have a single AI win they can point to. Very few have turned that win into something consistent, trusted, and enterprise wide.
The honest answer is uncomfortable for anyone who has spent two years buying models and tools: the bottleneck is almost never the model. It is the data underneath it, and the plumbing that is supposed to move that data between systems. A pilot succeeds because someone hand assembled a clean dataset for it. Scaling fails because that heroics-driven setup does not survive contact with the rest of the estate.
What the jump from pilot to production really demands
Scaling is not running the same pilot in more departments. It is the shift from a single, supervised proof of concept to a capability that runs reliably across many workflows, many sites, and many data sources without a specialist babysitting it. That means the same model has to receive data in the same shape whether it comes from an imaging archive, a lab system, a clinical trial database, or a commercial dataset bought from a third party.
Put differently, a pilot proves the model can be useful once. Scaling proves the organization can feed that model correctly, repeatedly, and auditably, at volume, while the underlying systems keep changing. Those are different problems. The first is a data science problem. The second is a data engineering and architecture problem, and it is the one that quietly decides whether the investment ever pays off.
Why most pilots stall before they scale
The numbers are sobering and consistent across independent analysts. Gartner has projected that at least 30 percent of generative AI projects will be abandoned after proof of concept, with poor data quality named as one of the primary causes. BCG's 2025 research on enterprise AI found that roughly 60 percent of companies were reaping hardly any material value from their AI investment, while only a small minority had reached the stage of generating real, scaled returns.
Read those two findings together and a pattern emerges. The failure is rarely that the model could not do the task. The failure is that the organization could not supply the model with trustworthy data at the scale and consistency that production demands. Peer-reviewed and policy research points the same way. The OECD's work on scaling AI in health identifies fragmented data foundations and structural and governance barriers as core reasons the technology's potential is not realized. A 2025 systematic review of AI platform architecture in hospital systems found that most reported implementations target isolated tasks, such as a single triage or imaging algorithm, and that few organizations have built the system-level roadmap and governance needed to move from pilot to enterprise scale.
In other words, the thing that makes a pilot easy is exactly the thing that makes scaling hard. A pilot lets you cheat. You can curate a clean slice of data by hand. Production does not let you cheat, because the data never stops arriving and it never arrives clean.
The integration layer is the real bottleneck
When teams say "we have a data problem," they usually mean three separate problems wearing one coat.
The first is fragmentation. Critical information sits in systems that were never designed to talk to each other: imaging archives, laboratory systems, electronic health records from different vendors, trial databases, and an expanding set of device and wearable streams. The systematic review of hospital AI architecture describes this directly, citing siloed imaging and lab systems and inconsistent adoption of interoperability standards such as HL7 FHIR across EHR vendors as a primary barrier. Standards exist. Consistent adoption of them does not.
The second is semantic mismatch. Even when two systems can exchange a file, the same clinical or operational concept is often coded differently in each. Until those meanings are reconciled, you do not have integrated data. You have two incompatible spreadsheets in the same folder.
The third is the human cost of papering over the first two. Cleaning and preparing data remains one of the most labor-intensive parts of any data science effort, and in healthcare it is heavier still because the data is sensitive, irregular, and high stakes. When that work is done manually for every pilot, it does not compound. Each new use case starts the cleaning from scratch, which is the opposite of scaling.
The takeaway is blunt: the gating step for scaling AI in healthcare is making complex clinical and operational data usable across systems. Solve that once, properly, and the models you already have start to work everywhere. Skip it, and you buy a more expensive model that fails in the same place the last one did.
What good looks like in practice
Organizations that scale AI have usually built four things before they buy their next model, and they tend to build them in this order.
They build a unified data layer first, so that information from many source systems lands in one governed place in a consistent shape. They build the pipelines that move and reshape that data automatically, so preparation stops being a manual ritual repeated per project and becomes infrastructure that runs on its own. They build a cloud architecture underneath that can grow with demand and separate environments cleanly, so a model in production is not sharing fragile resources with a half-finished experiment. And only then do they put an AI usability layer on top, the part that lets clinicians, analysts, and operational staff actually ask questions of the data without writing code or waiting in a queue.
That sequence matters. The visible AI is the last layer, not the first. The reason so many organizations are stuck is that they bought the top layer and never built the three underneath it. Reverse the order and the same model that failed to scale last year suddenly behaves, because for the first time it is being fed correctly.
Why life sciences feels this hardest
Every industry has data sprawl. Life sciences has data sprawl plus three multipliers.
The data volumes are large and growing, spanning trials, commercial datasets, real-world evidence, and device streams. The work is multi-country, which means the same dataset has to be reconciled across different national systems and conventions. And the environment is regulated, so the data layer cannot be a black box. It has to be traceable, governed, and audit-ready by default, with clear lineage from source to output. A consumer tech company can ship a model that is roughly right. A regulated life sciences organization has to be able to show its work.
This is why the integration layer is not a "nice to have" in this sector. It is the precondition for using AI in production at all. The organizations that treat the data foundation as the project, rather than as a chore to get past on the way to the model, are the ones quietly pulling ahead.
Common signs your environment is not ready to scale
A quick diagnostic. If several of these are true, the next model purchase will not fix it.
A new AI use case still requires weeks of manual data wrangling before it can begin. The same dataset is described differently in two systems and nobody owns the reconciliation. Your successful pilots have not spread beyond the team that built them. Moving to production means re-engineering the data flow from scratch each time. Nobody can produce a clean lineage of where a given number came from. And the people closest to the data spend more time preparing it than analyzing it.
None of these are model problems. All of them are foundation problems, and all of them are fixable.
Where the business case shows up
This is not theoretical. The pattern repeats across the data engineering work we see in life sciences.
In one engagement, a market access analytics platform built for a large research organization unified more than 50 national datasets into a single governed layer, served over 1,000 users across more than 15 countries, and cut manual data preparation by around 60 percent. The model layer was not the hard part. The integration layer was, and once it existed the analytics scaled to a global user base instead of staying trapped in one team.
In another, a domain-specific AI agent let a life sciences data team query their data in plain language across more than 250 curated fields. Queries ran about 35 percent faster and the volume of data people could actually reach grew roughly tenfold. The unlock was not a cleverer model. It was that the data beneath it had been organized and governed so the model could be trusted to answer.
In both cases the visible AI was the smallest part of the work. The durable value came from the foundation that let it scale.
Where the sales angle naturally fits
If your AI pilots are working but not spreading, the problem is probably one layer below where you have been looking. That is the layer DataDrill is built for. We work as an embedded data engineering partner for life sciences organizations, focused on exactly the four building blocks above: unifying fragmented data, automating the pipelines that prepare it, building cloud architecture that scales in regulated environments, and putting a usable AI layer on top once the foundation can support it. We tend to start small and fast, with a tightly scoped pilot of a few weeks against one real bottleneck, so the value is visible before anyone commits to a larger build. The goal is not to add another tool to the stack. It is to make the AI you already believe in actually work everywhere.
Final thought
The hard part of AI in healthcare was never teaching the model to be useful once. It is building the data foundation that lets it be useful everywhere, every day, for everyone who needs it.
FAQ
Why do healthcare AI pilots succeed but fail to scale?
A pilot usually runs on a clean dataset that someone assembled by hand for that one use case. Production data arrives continuously from many systems, in inconsistent formats, and never stops. Without an integration layer that prepares data automatically and consistently, every new use case restarts the manual work, so the win never compounds into scale.
Is the bottleneck the AI model or the data?
Almost always the data and the infrastructure around it. Independent analyst research repeatedly traces stalled AI initiatives back to data quality and the absence of a foundation that can move information into production reliably, rather than to the capability of the model itself.
What does interoperability actually require beyond a standard like FHIR?
Standards let two systems exchange data, but they do not guarantee that the same clinical or operational concept is coded the same way in each system. Real interoperability needs semantic reconciliation on top of the standard, plus governance so the meaning stays consistent as systems change.
How long does it take to build a data foundation that can scale AI?
It does not have to be a multi-year platform rebuild. A focused pilot against one real bottleneck, scoped to a few weeks, can prove the approach and produce visible results before any larger investment. The foundation then grows incrementally from a working core.
Why is this harder in life sciences than in other industries?
Three multipliers: large and growing data volumes, multi-country reconciliation, and a regulated environment that requires traceable, governed, audit-ready data with clear lineage. The data layer cannot be a black box, which raises the bar for the foundation that any production AI depends on.
Ready to Transform Your Data Infrastructure? If your AI works in the pilot but stalls before scale, the gap is usually in the data layer underneath it. Let's talk about a short, focused engagement against your biggest bottleneck. Visit /contact.